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Photochemical stabilityS-nitrosothiols (RSNOs) remain one of the most popular classes of NO-donating compounds due to their
ability to release nitric oxide (NO) under non-enzymatic means whilst producing an inert disulphide by-
product. However, alligning these compounds to the different biological fields of NO research has proved
to be problematic due to the inherent instability of such compounds under a variety of conditions includ-
ing heat, light and the presence of copper ions. 1,3,2-Oxathiazolylium-5-olates (OZOs) represent an inter-
esting subclass of S-nitrosothiols that lock the –SNO moiety into a five membered heterocyclic ring in an
attempt to improve the compound’s overall stability. The synthesis of a novel series of halogen-contain-
ing OZOs was comprehensively studied resulting in a seven-step route and overall yields ranging
between 21 and 37%. The photochemical stability of these compounds was assessed to determine if S-
nitrosothiols locked within these mesoionic ring systems can offer greater stability and thereby release
NO in a more controllable fashion than their non-cyclic counterparts.
 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The exogenous supply of nitric oxide (NO) can offer therapeutic
benefit to a number of different medical conditions including those
associated with blood flow, cancer and wound healing, in addition
to many others.1 Since the discovery in the 1980s2 of NO as an
important signalling molecule in cells and tissues there have been
many studies focusing on the design and synthesis of NO-donating
compounds, leading to an extensive array of reviews on the topic.3
Of the dozen or so different classes of NO-donors that exist, the
nitrates, furoxans, diazeniumdiolates and S-nitrosothiols are
amongst those most commonly cited.4
The S-nitrosothiols, also known as the thionitrites or RSNOs, are
a particularly interesting class of NO donor as there is clear evi-
dence that these also exist endogenously, as NO reservoirs, by
the in vivo nitrosation, of cysteine, glutathione, albumin and
haemoglobin.5 These same thiols, can take part in NO transfer
(transnitrosation) reactions when in the presence of RSNOs, thus
allowing NO to effectively leap-frog from one thiol to another.6
The homolytic cleavage of the S-N bond in such compounds gener-
ates nitric oxide as a stable free radical and the corresponding
disulphide, which is formed in a termination step involving two
thiyl radicals. This process, leading to the generation of one mole
of NO for every mole of RSNO is particularly attractive and intrigu-ing to chemists due to the colour changes associated with NO
release. Whilst primary and secondary S-nitrosothiols, such as S-
nitrosocysteine (SNO-Cys) 1 and S-nitrosoglutathione (GSNO) 2
are characteristically pink or red in colour, tertiary derivatives,
such as S-nitroso-N-acetyl-penicillamine (SNAP) 3 give green com-
pounds (Fig. 1).3 The release of NO from these RSNOs can be easily
viewed by their loss of colour and more specifically, can be moni-
tored by the degradation of characteristic kmax at 330–350 nm and
at 550–600 nmwhen using UV/Vis spectrophotometry.3 The condi-
tions that bring about NO release from RSNOs include light, heat
and the presence of copper ions (Eq. (1)), with the latter being of
particular interest since extensive work 20 years ago showed that
Cu(I) rather than Cu(II) was responsible for weakening the S-N
bond and catalysing this decomposition step.7 In a twist of added
complexity the disulphide by-product (e.g. GSSG), formed follow-
ing NO release from certain RSNOs (e.g. GSNO 2) can behave as a
metal ion chelator and therefore remove copper from the solution
resulting in the prolonged existence of the RSNO whilst signifi-
cantly reducing the levels of free NO.8
2 RSNO !D;hv or Cu
þ
RSSR þ 2NO ð1Þ
Subtle structural differences, including even those between
SNO-Cys 1 and SNAP 3, have been shown to dramatically alter
the stability of these compounds and thus the rate at which they
release NO.9 In the case of compound 3, the greater steric bulk
Fig. 1. Previously reported S-nitrosothiols (1–5).
Fig. 2. Target halogen-containing OZO compounds (5b–5g).
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SNO moiety to form a tertiary S-nitrosothiol can aid stability by
reducing both the ease of copper complexation and thiyl radical
dimerization.10 Such subtleties that influence NO release have fas-
cinated the authors and co-workers over many years, which ini-
tially led to the synthesis of a large number of carbohydrate
based S-nitrosothiols (including SNAG 4) to help explore the key
chemical features effecting the stability of the –SNO moiety
(Fig. 1).11 The key result of the carbohydrate-based work, which
looked at varying the lipophilicity, sugar type and even the chiral
form, was to confirm that such compounds are intrinsically unsta-
ble, with many decomposing upon the removal of solvent without
the need for any of the aforementioned decomposition conditions.
Rather than fine-tuning the stability, this emphasised the need for
a much coarser handle on controlling RSNO stability, which led to
interest in 4-aryl-1,3,2-oxathiazolylium-5-olates (OZOs) 5a (Fig. 1),
where the –SNO group is locked into a five-membered heterocyclic
ring in an attempt to gain greater control over NO release.12
Previous work involving carbohydrate based RSNOs, such as
SNAG 4, showed by laser Doppler imaging to bring about a signif-
icant dose dependent vasodilator effect (P = 0.001) to forearm
microvessels following transdermal delivery. A five-fold enhance-
ment in peripheral blood flow over baseline was seen using the
highest SNAG 4 concentration (0.75%, w/w) with intra- and inter-
subject variability of 19% and 16%, respectively.11 Such applica-
tions, where the NO-donor is supplied at or close to the site of
action circumvents, to some degree, the need for highly stable S-
nitrosothiols since degradation is ultimately essential for the quick
and local supply of NO. However, in an attempt to synthesise and
test longer acting RSNOs with improved storage capabilities, the
4-aryl-1,3,2-oxathiazolylium-5-olates were studied with particular
interest in the required ring-opening step prior to RSNO degrada-
tion and NO release.
Decomposition of 4-aryl-1,3,2-oxathiazolylium-5-olates by
photochemical unimolecular reactions were reported over 30 years
ago13 whilst thermal degradation has also been described at tem-
peratures of 80–140 C.14 More recently this same family of com-
pounds were shown to decompose when exposed to pH values
close to 5, which would match quite nicely to the skin pH range.15
In this latter work, the ring-opening step required prior to NO
release was shown to depend on the type of substituent attached
to the aryl ring. Based on these findings this work attempted to
expand this family of compounds with a focus on chloro and fluoro
derivatives, since previous findings reported that a 40-chloro sub-
stituent added stability.15 The incorporation of halogens onto the
aromatic ring may also serve to improve the overall lipophilicity
of the OZO and thus make them attractive candidates to study as
peripheral vasodilators via the transdermal delivery route. To fur-
ther explore the role of the substituents, placement on the ring at
the 20, 30 and 40 positions was explored as well as di-substitutedring derivatives. As a control, the aryl ring with no substituents,
which has been made previously,13,15–17 was re-synthesised in this
work and subjected to the same photochemical stability testing. All
halogen-containing target compounds (5b–5g) are summarised in
Fig. 2.
The first successful OZO synthesis dates back to 1960 when Bac-
chetti and Alemagna chose to study such compounds with a view
to taking advantage of the characteristic mesoionic ring.17 Similar
rationale led Gotthardt to propose a four-step synthesis in the
1970s and 80s,13,18 before Shaffer and Thompson outlined a six-
step synthesis in the 1990s,16 by which time the significance of
NO and the role of OZOs as NO-donors had been realised, leading
to a patent on their potential use as cardiovascular agents.16 In
2007, Wang proposed an additional route in four-steps with over-
all yields ranging from 39 to 51%, which to date, are the highest to
be reported for this compound class.15 In common with all earlier
examples, the work reported here uses the mandelic acids as start-
ing materials to outline a synthetic route, which the authors
believe to be more robust and reliable than previous methodology
(Scheme 1).
From all previous synthetic approaches the Mitsunobu reaction,
as described by Wang,15 was initially seen as the most attractive
and efficient means of replacing the benzylic secondary alcohol
in 6awith an S-acetyl group. This chemistry relies on the formation
of a complex between diisopropyl azodicarboylate (DIAD) and
triphenyl phosphine, which then deprotonates the benzylic alcohol
before thiolacetic acid is added, to provide the S-acetyl derivative.
However, this approach could not be replicated in this work
despite manipulating the order of addition and reaction times, as
well as tinkering with the number of equivalents of each reagent.
The lack of desired product was attributed to the carboxylic acid
being by far the most acidic group and therefore being the pre-
ferred site of de-protonation. With this in mind, the carboxylic acid
was converted into the methyl ester 7a. This step, using sulphuric
acid and methanol, proceeded without the need for further purifi-
cation in a 68% yield, which is consistent with literature values.19
The Mitsunobu reaction involving 7a still proved to be problematic
even when the thiol was replaced with the thiolate in an attempt
to produce a better nucleophile.
Attention switched to a bromination and S-acetylation as two
separate steps, using HBr to yield 8a20 and 1.1 equivalents of KSAc
to give 9a (see Scheme 1). When repeated on a larger scale it was
found that PBr3 was a preferable route to 8a, which mirrors the
approach taken by Shaffer and Thompson.16 After washing through
a silica pad, brominated product 8a was obtained in 75% yield and
in pure form, whilst S-acetyl 9a gave an orange oil in a yield of 95%
that did not require further purification. Unlike Shaffer and
Scheme 1. The preferred synthetic route for OZO 5a and the halogenated OZOs (5b–5g). (i) H2SO4, MeOH, 60 C, 4 h. (ii) 1.1 equiv. PBr3, CHCl3, r.t., 96 h. (iii) 1.1 equiv. KSAc,
MeOH, r.t., 4 h. (iv) NaOMe/MeOH, r.t., 5 h. (v) H2SO4/H2O, 0 C, 24 h. (vi) 2 equiv. iBuONO/CH2Cl2, 0 C, 2 h. (vii) 1 equiv. polymer bound DCC, CH2Cl2, 0 C, 2 h.
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chloroform at room temperature, rather than using refluxing con-
ditions. Dry dichloromethane, carbon tetrachloride and tetrahy-
drofuran were also tested in parallel as potential solvents for the
bromination step at temperatures ranging from 0 C to 60 C, but
chloroform proved to be the best compromise with regards to
safety, yield and reaction time.
The de-S-acetylation step used the same methodology as
Wang15 to yield the free thiol 10a in 90%, without the need for
purification as none of the corresponding disulphide was identi-
fied. Hydrolysis of the methyl ester to give 11a proved more diffi-
cult due to the generation of disulphide when using basic
conditions. As a result, a variety of different reagents and condi-
tions were studied and the deprotection sequence for the S-acetyl
and methyl ester groups was also reversed and attempted in a sin-
gle step, without success. After multiple attempts involving NaOH,
LiOH, NaOMe, HCl and BBr3, the best compromise was found to be
the use of dilute sulphuric acid at 0 C, which gave pure 11a in 93%
yield.
Nitrosation of the thiol to give the desired S-nitrosothiol has
previously been attempted20,21 using tert-butyl nitrite, ethyl nitrite
and iso-butyl nitrite, with the latter proving to be the preferred
reagent in this work to give 12a, which was immediately reacted
on to give the ring-closed OZO compound 5a. Attempts were also
made to nitrosate using the N2O4 and N2O3 fuming method,11 how-
ever, nitrosation of the ethanol solvent10 led to the requirement for
an inert gas to be bubbled through the product in order to remove
excess fumes, and nitrous acid was also formed as a by-product,
which was seen as a major disadvantage. Hart’s sodium nitrite
method22 was also trialled here using an acidified aqueous mixture
that relies on precipitation when the reaction mixture is cooled,
but in this work no solid product was seen using this approach.
The ring-closing dehydration step was previously described
using DCC,15 however, following filtration through a Celite pad to
remove excess iso-butyl nitrite and column chromatography, thedesired product 5a was found to co-elute with residual DCC. Due
to this, EDC was substituted in place of DCC, which led to a very
low yield due to solubility issues during the aqueous work-up. In
light of these yield and purification problems, polymer bound
DCC was instead used, since this was simply filtered off following
the ring-closure reaction, to give OZO 5a in 90% from the free thiol
11a, after column chromatography.
This modified seven-step synthesis, which is clearly a longer
route than those previously described,13,15–17 was seen as a reliable
and robust method to give OZO 5a in a yield of 37%. Despite this
pathway having a yield that was 14% lower than that reported else-
where15 this method consistently converted starting materials 6a–
6g into OZOs 5a–5g in overall yields ranging between 21 and 37%,
with five of these products being novel OZO examples.
The instability of S-nitrosothiols under a variety of different
conditions has been well documented over the last twenty-five
years with reported half-lifes ranging from 2 s to in excess of 9.5
months (see Eq. (1)).23 This work does not wish to address the rel-
ative stability of S-nitrosothiols 12a–12g, rather, the focus here
was to ascertain if any improvements in photochemical stability
can be achieved with ring-locked RSNOs; thus the ring opening
of OZOs 5a–5g was monitored. With this in mind, a decomposition
study was designed to establish the time and conditions required
to convert 5a–5g into 13a–13g. Identification of ring-opened
derivatives (13a–13g) was best achieved in one-pot using the Sav-
ille reaction in combination with the Griess test as presented in
Scheme 2.24
Previous work has shown that OZOs will photochemically ring-
open via one of two different pathways, which is dependent on the
polarity of the solvent used.25 The photochemical reaction in ben-
zene results in a phenylthiazirine intermediate on route to a
phenylnitrile derivative, whilst in ethanol the free S-nitrosothiols
derivatives 13 are formed, which subsequently results in NO
release; thus the latter solvent model was adopted in this work.
Photochemical decomposition at room temperature was studied
Scheme 2. Monitoring the ring opening step using UV/Vis spectrophotometry in a
one-pot method utilising the Saville reaction in combination with the Griess test.
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formation of the purple azo dye 16 following the Saville and Griess
reactions (Scheme 2).24 This model NO releasing system, which
was calibrated using GSNO 2, allowed the rate of ring-opening to
be monitored and compared for 5a–5g. All OZO compounds were
dissolved in EtOH:H2O (1:1) at an initial concentration of 75 mM
and an equimolar concentration of HgCl2, sulphanilamide 14 and
N-(1-naphthyl)ethylenediamine 15 was included in each sample.
The first series of experiments examined NO release at room
temperature under dark conditions. This highlighted 5a, 5c, 5e
and 5g as being the least stable with all four showing between
40% and 80% ring opening without any light exposure. Since com-
pounds 5b, 5d and 5f showed greater stability these were further
explored in the presence of ambient daylight conditions, alongside
5e, which served as a comparison from the less stable derivatives.
The results of this work are displayed in Fig. 3. From this photo-Fig. 3. The percentage ring-opening of OZOs (5b, 5d, 5e & 5f) after 40 min at 25 C
when either left in the dark (black shading) or exposed to ambient daylight levels
(grey shading).chemical stability study three key observations were identified:
(1) the fluoro OZOs were generally less stable than the chloro OZOs
(cf. para fluoro 5e showed 76% decomposition versus 42% for para
chloro 5d); (2) in the chloro series the stability order was ortho, 5b
> para, 5d > meta, 5c; (3) in the fluoro series the ortho and para di-
substituted derivative 5f was more stable than the mono-substi-
tuted para fluoro derivative 5e. This latter observation is consistent
with the ortho position providing greater stability as explained by
observation (2).
Whilst it is fascinating to observe these stability differences, it is
challenging to rationalise how such subtle substituent changes can
afford such large variability in the rate of the photochemical ring-
opening step. As outlined in previous work,15 there is clearly a link
between OZO stability and the level of electron-donation or elec-
tron-withdrawal provided by the substituent on the benzene ring,
with the latter reducing stability and the former prolonging the
existence of the OZO compound when in solution.
For OZO 5a previous work found 7% overall decomposition and
NO release when exposed to light over a 3-h period,15 however, in
this work 48% decomposition was observed in the dark over a 40-
min period. Although this would tend to suggest a large discrep-
ancy between studies, it is very important to note that this study
is designed to only focus on the ring-opening event as beyond this
step all RSNO is instantly degraded by HgCl2, as was desired by the
authors, thus the two sets of data should not be directly compared.
The OZOs in this series clearly release NO over a greater time per-
iod than suggested by the data in Fig. 3 as these results are based
on the complete breakage of the S-N bond upon generation of the
free S-nitrosothiol due to the presence of HgCl2 which enables the
Saville reaction to yield the nitrosonium ion that is needed for the
generation of the azo-dye from the reaction with 14 and 15. Whilst
the purple dye acts as marker for OZO decomposition in this stabil-
ity model, in reality, the free S-nitrosothiol will exist in solution
and therefore release NO over a greater time period. As such, it is
important to reiterate that this study was only concerned with
monitoring the added stability, if any, that the mesoionic rings pro-
vide to such compounds.
In summary, when dissolved in a dilute ethanolic solution the
OZO compounds described in this work provide only a minimal
advantage over their ring-opened counterparts. It is fair to con-
clude that whilst OZOs do not fully address the issues surrounding
S-nitrosothiol instability in solution, they do afford analogues that
can be isolated and stored more easily in the solid form than some
acyclic –SNO moieties (e.g. SNAG, 4), which spontaneously decom-
pose in the solid state.11,25 This particular issue explains the one-
pot method used for steps 6 and 7 of the OZO synthesis outlined
in this work (Scheme 1) where the free RSNO formwas not isolated
on route to the final ring-closed OZO products. Furthermore, in
solution, it has been shown here that OZOs do provide extra stabil-
ity, due to the added necessity of the ring-opening step, albeit not
the kind of stability that is optimal for the slow, controlled delivery
of NO over many hours. OZOs should therefore be viewed as a par-
tial rather than the complete answer to enhancing RSNO stability.
In addition to expanding the number of OZO derivatives for appli-
cations tailored towards NO related studies, the improved syn-
thetic methodology outlined in this work will undoubtedly
interest those wishing to further explore cycloaddition reactions
involving OZO compounds.25
The modified synthetic sequence described in this work suc-
cessfully yielded five novel OZO derivatives (5b, 5c, 5e–g), which
in solution were shown to ring-open within minutes when
exposed to ambient light conditions and thus produce the naked,
acyclic form of the S-nitrosothiol. As such the improved stability,
in solution, gained by these ring-locked S-nitrosothiols was only
considered to be a partial success. The added synthetic challenge
in forming these mesoionic rings was rewarded with RSNOs of
1110 M. Eilertsen et al. / Bioorganic & Medicinal Chemistry Letters 28 (2018) 1106–1110greater stability in the solid form when compared to acyclic RSNOs
(e.g. SNAG, 4), however, in solution these compounds did not pro-
vide the level of tailored stability that is desired by those wishing
to further investigate the role, if any, of exogenous NO when deliv-
ered to a variety of different biological models. So, whilst S-
nitrosothiols remain one of the most attractive categories of NO-
donor available, the focus on improving the overall stability should
consider studying the importance that other functionality has on
the rate of NO release from the –SNO moiety. In short, the medic-
inal chemist’s work is far from complete in identifying the key
structural features that have the greatest influence on the rate of
NO release from this intriguing class of compounds.
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